1. Raddeanin A suppresses intracellular 5 Methylcytosine DNA modification engaged the metastasis of hepatocellular carcinoma.
- Author
-
Liu X, Xie X, Wang K, Liu X, Gong J, Yang Z, and Li J
- Subjects
- Humans, Hep G2 Cells, 5-Methylcytosine analogs & derivatives, 5-Methylcytosine metabolism, Antineoplastic Agents, Phytogenic pharmacology, Cell Movement drug effects, DNA Methyltransferase 3A, DNA (Cytosine-5-)-Methyltransferases metabolism, Animals, Cell Line, Tumor, DNA Methyltransferase 3B, Saponins, Carcinoma, Hepatocellular drug therapy, Carcinoma, Hepatocellular pathology, Carcinoma, Hepatocellular metabolism, Liver Neoplasms drug therapy, Liver Neoplasms pathology, DNA Methylation drug effects, Apoptosis drug effects
- Abstract
Ethnopharmacological Relevance: The Anemonoides Raddeana (Rege) Holubhe is commonly employed in clinical practice as a traditional Chinese medicine for the treatment of conditions such as rheumatism and limb numbness. Raddeanin A (RA), an active compound derived from this Traditional Chinese Medicine (TCM), demonstrates specific anticancer properties against many tumorigeneses. However, the molecular mechanism underlying its effects on hepatocellular carcinoma (HCC) remains unexplored., Aim of the Study: The aim of this study is to investigate the inhibitory effects of RA in human HCC stimulated cells and its impact on DNA methylation in tumor cells, as well as to elucidate the molecular mechanisms underlying RA's anti-tumor activity., Materials and Methods: The inhibitory effects of RA on QGY-7703 and HepG2 cells were evaluated. The IC
50 values were determined by employing non-linear sigmoidal curve fitting to analyze the normalized response. The impact of RA was investigated in cells overexpressing DNMT3A and DNMT3B. The effects of RA on cell cycle progression and apoptosis were assessed. Furthermore, the influence of RA on cellular methylation was determined, along with its effects on the expression levels of DNMT3A, DNMT3B, Bcl-2, Bax, and Caspase-3., Results: The findings demonstrate that RA induces cell cycle arrest at the G0/G1 phase and promotes apoptosis in hepatocellular carcinoma cells. Furthermore, RA effectively inhibits the invasion and migration of human HCC stimulated cells. The expression of DNMT3A and DNMT3B is downregulated by RA, effectively suppressing the intracellular5 mC DNA modification level. Moreover, the overexpression of these enzymes in RA-treated human HCC stimulated cells significantly impacts the overall5 mC level and hinders tumor metastasis by restricting migration and invasion., Conclusion: The RA compound acts as an antagonist against HCC by reducing intracellular DNA5 mC levels through mechanisms mediated by methyltransferase. Moreover, RA demonstrates the capacity to induce apoptosis in tumor cells, thereby exerting its anti-tumor effects. The findings of this study provide valuable insights for enhancing the pharmacodynamic efficacy of RA in HCC treatment., Competing Interests: Declaration of competing interest The authors affirm that they possess no known competing financial interests or personal relationships that could have been perceived as exerting influence on the findings presented in this paper. The authors disclose the absence of any financial interests or personal relationships which may be considered potential competing interests., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2025
- Full Text
- View/download PDF